Immunoglobulin - FOI Response Register

FoI Number
2023-771
Subject
Immunoglobulin
Date Received
11/03/2024
Request and Response
  1. In the past 3 months, how many patients have received the following treatments (for any disease
  • Berinert (Human C1-esterase inhibitor) 
  • Cinryze (Human C1-esterase inhibitor) 
  • Firazyr (Icatibant)
  • Icatibant - any brand except Firazyr
  • Orladeyo (Berotralstat)
  • Ruconest (Recombinant human C1-esterase inhibitor) 
  • Takhzyro (Lanadelumab) 

ZERO

  1. In the past 3 months, how many patients have received the following immunoglobulin treatments (for any disease):
  • Cutaquig       0
  • Cuvitru           0
  • Gammagard              0
  • Gammanorm             0
  • Hizentra                     0
  • Hyqvia                        0
  • Intratect                      0
  • Iqymune                    0
  • Kiovig                         0
  • Privigen                     1
  • Octagam                    0
  • Panzyga                    0
  • Subgam                     0
  • Any other normal immunoglobulin 0